511 related articles for article (PubMed ID: 11859512)
1. [Cancer immunotherapy].
Vakkila J; Pihkala U
Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
[No Abstract] [Full Text] [Related]
2. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
3. Third international Dresden symposium on immunotherapy of cancer.
Schmitz M; Bornhauser M; Ockert D; Rieber EP
Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317
[No Abstract] [Full Text] [Related]
4. Immunotherapy of metastasis.
Dallal RM; Lotze MT
Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
[TBL] [Abstract][Full Text] [Related]
5. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: the state of the art.
Finn OO; Banchereau J
Semin Immunol; 2010 Jun; 22(3):103-4. PubMed ID: 20552730
[No Abstract] [Full Text] [Related]
8. [Immunology: new approaches to immuno-modulation and immunotherapy].
Kabelitz D
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
[No Abstract] [Full Text] [Related]
9. [Advances in immunotherapy for pediatric cancer].
Xu X; Zhao H; Tang Y
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):231-4. PubMed ID: 24824398
[No Abstract] [Full Text] [Related]
10. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells in cancer immunotherapy - a short review.
Wojas K; Tabarkiewicz J; RoliĆski J
Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines for established cancer: how to make them better?
Andrews DM; Maraskovsky E; Smyth MJ
Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
[TBL] [Abstract][Full Text] [Related]
14. Personalized cancer vaccines.
Jain KK
Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567
[TBL] [Abstract][Full Text] [Related]
15. First-in-class cancer therapeutic to stimulate natural killer cells.
Sheridan C
Nat Biotechnol; 2006 Jun; 24(6):597. PubMed ID: 16763573
[No Abstract] [Full Text] [Related]
16. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
Fujii S
Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
[No Abstract] [Full Text] [Related]
17. Analyses and perspectives in cancer immunotherapy.
Nguyen van Binh P; Duc HT
Biomed Pharmacother; 2006 Nov; 60(9):621-8. PubMed ID: 16978826
[TBL] [Abstract][Full Text] [Related]
18. [Dendritic cells and immunotherapy of liver cancer].
Cao XT
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):133-4. PubMed ID: 12681054
[No Abstract] [Full Text] [Related]
19. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
20. [Cell therapy in solid tumors].
Ravaud A
Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
[No Abstract] [Full Text] [Related]
[Next] [New Search]